Dopamine transporter immunoreactivity in peripheral blood lymphocytes in multiple system atrophy

Journal of Neural Transmission

Volumn 116, Issue 2, 2009, Pages 161-165

  Buttarelli, Francesca R ^a   Circella, Annapia ^b   Pellicano, Clelia ^a,c   Tiple, Dorina ^a   Giovannelli, Morena ^c   Colosimo, Carlo ^a   Pontieri, Francesco E ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Dopamine transporter; Immunocytochemistry; Multiple system atrophy; Peripheral blood lymphocytes

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; OXIDATIVE STRESS; PARKINSON DISEASE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SHY DRAGER SYNDROME;

AGED; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEVODOPA; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY;

EID: 59849096762     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-008-0170-0     Document Type: Article

References (27)

1. F Amenta E Bronzetti L Felici 1999 Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study J Auton Pharmacol 19 151 159
2. F Amenta E Bronzetti F Cantalamessa 2001 Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes J Neuroimmunol 117 133 142
3. MJ Bannon CJ Whitty 1997 Age-related and regional differences in dopamine transporter mRNA expression in human midbrain Neurology 48 969 977
4. N Barroso Y Campos R Huertas 1993 Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson's disease Clin Chem 39 667 669
5. C Battisti P Formichi E Radi 2008 Oxidative stress-induced apoptosis in PBLs of two patients with Parkinson's disease secondary to alpha-synuclein mutation J Neurol Sci 268 183 186
6. 123I]-FP-CIT Study Group Mov Disord 15 503 510
7. J Bergquist A Tarkowski R Ekman 1994 Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop Proc Natl Acad Sci USA 91 12912 12916
8. F Blandini M Cosentino A Mangiagalli 2004 Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effects of dopaminergic treatment J Neural Transm 111 1017 1030
9. F Blandini E Sinforiani C Pacchetti 2006 Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease Neurology 66 529 534
10. GD Borasio R Linke J Schwarz 1998 Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography J Neurol Neurosurg Psychiatry 65 263 265
11. DJ Brooks KA Frey KL Marek 2003 Assessment of neuroimaging techniques as biomarkers of progression of Parkinson's disease Exp Neurol 184 suppl. 1 S78 S89
12. FR Buttarelli A Circella C Pellicano 2006 Dopamine transporter immunoreactivity in peripheral blood lymphocytes in amyotrophic lateral sclerosis Eur J Neurol 13 416 418
13. Buttarelli FR, Capriotti G, Pellicano C et al. (2008) Central and peripheral dopamine transporter reduction in Parkinson's disease. Neurol Res (in press)
14. B Caronti G Antonini C Calderaro 2001 Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease J Neural Transm 108 803 807
15. B Caronti G Tanda C Colosimo 1999 Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease Neuroreport 10 2907 2910
16. AJ Hughes SE Daniel L Kilford 1992 Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181 184
17. S Gilman PA Low N Quinn 1999 Consensus statement on the diagnosis of multiple system atrophy J Neurol Sci 163 94 98
18. M Jimenez Del Rio C Velez-Pardo 2000 17 beta-Estradiol protects lymphocytes against dopamine and iron-induced apoptosis by a genomic-independent mechanism. Implication in Parkinson's disease Gen Pharmacol 35 1 9
19. S Kim BS Jeon C Heo 2004 Alpha-synuclein induces apoptosis by altered expression in human peripheral lymphocyte in Parkinson's disease FASEB J 18 1615 1617
20. D Marazziti S Baroni M Catena Dell'Osso 2008 Presence and characterization of the dopamine transporter in human resting lymphocytes Neurochem Res 33 1011 1016
21. L Migliore L Petrozzi C Lucetti 2002 Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients Neurology 58 809 815
22. C Pellicano FR Buttarelli A Circella 2007 Dopamine transporter immunoreactivity in peripheral blood lymphocytes discriminates Parkinson's disease from essential tremor J Neural Transm 114 935 938
23. L Petrozzi C Lucetti G Gambaccini 2001 Cytogenetic analysis of oxidative damage in lymphocytes of Parkinson's disease patients Neurol Sci 22 83 84
24. A Ricci E Bronzetti F Mignini 1999 Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes J Neuroimmunol 96 234 240
25. LC Seeberger RA Hauser 2007 Optimizing bioavailability in the treatment of Parkinson's disease Neuropharmacology 53 791 800
26. GR Uhl 1998 Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease Ann Neurol 43 555 560
27. GK Wenning C Colosimo F Geser 2004 Multiple system atrophy Lancet Neurol 3 93 103